20 reports of this reaction
7.5% of all CARBON DIOXIDE reports
#2 most reported adverse reaction
SUBCUTANEOUS EMPHYSEMA is the #2 most commonly reported adverse reaction for CARBON DIOXIDE, manufactured by A-OX Welding Supply, LLC. There are 20 FDA adverse event reports linking CARBON DIOXIDE to SUBCUTANEOUS EMPHYSEMA. This represents approximately 7.5% of all 267 adverse event reports for this drug.
Patients taking CARBON DIOXIDE who experience subcutaneous emphysema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SUBCUTANEOUS EMPHYSEMA is moderately reported among CARBON DIOXIDE users, representing a notable but not dominant share of adverse events.
In addition to subcutaneous emphysema, the following adverse reactions have been reported for CARBON DIOXIDE:
SUBCUTANEOUS EMPHYSEMA has been reported as an adverse event in 20 FDA reports for CARBON DIOXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SUBCUTANEOUS EMPHYSEMA accounts for approximately 7.5% of all adverse event reports for CARBON DIOXIDE, making it one of the most commonly reported side effect.
If you experience subcutaneous emphysema while taking CARBON DIOXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.